SCHEMBL6696450

SCHEMBL6696450

Fc1cccc(Cl)c1CNc1cccc(NCc2c(F)cccc2Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.60
MAPT P10636 4/20 0.58
ALDH1A1 P00352 4/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
KDM4E B2RXH2 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
MAPK1 P28482 1/20 0.58
MPI P34949 1/20 0.58
HTT P42858 3/20 0.53
LCK P06239 4/20 0.51
BTK Q06187 4/20 0.51
GAA P10253 4/20 0.50
ATM Q13315 2/20 0.50
TAAR1 Q96RJ0 1/20 0.50
LMNA P02545 1/20 0.50
TSHR P16473 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAPK14 Q16539 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16679725 0.89 RXFP1 (0.64) RXFP1MAPTALDH1A1MEN1KMT2A
SCHEMBL6701678 0.89 RXFP1 (0.72) RXFP1MAPTALDH1A1MEN1KMT2A
SCHEMBL6690783 0.87 RXFP1 (0.44) RXFP1MAPTALDH1A1MEN1KMT2A
SCHEMBL6696124 0.85 RXFP1 (0.57) RXFP1MAPTALDH1A1MEN1KMT2A
SCHEMBL4343726 0.84 RXFP1 (0.59) RXFP1MAPTALDH1A1MEN1KMT2A
SCHEMBL4347945 0.84 RXFP1 (0.59) RXFP1MAPTALDH1A1MEN1KMT2A
SCHEMBL6693874 0.84 RXFP1 (0.52) RXFP1MAPTALDH1A1MEN1KMT2A
SCHEMBL4356068 0.83 RXFP1 (0.55) RXFP1MAPTALDH1A1MEN1KMT2A
SCHEMBL11510231 0.79 GAA (0.53) MAPTALDH1A1MEN1KMT2AKDM4E
SCHEMBL6691456 0.79 MEN1 (0.49) RXFP1MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups 4SC AG (DE) 2004-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups PAH, PNMT, OPRM1 RXFP1 2157/4885MAPT 3951/4885ALDH1A1 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.